Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.1044030
Abstract: Aim Gastrointestinal discomfort is the most common adverse event in metformin treatment for type 2 diabetes. The mechanism of action of metformin is associated with gut microbiota. However, the gut microbial community structure related to… read more here.
Keywords: group; scfa group; met scfa; met clin ... See more keywords